Macaulay Capital PLC
29 April 2024
Macaulay Capital PLC
("Macaulay Capital" or the "Company")
Grant of share options
Macaulay Capital PLC (AQSE:MCAP), which was formed to originate and manage corporate transactions, raise funds from third parties, invest its own funds alongside those of external investors and to manage its investment portfolio with the aim of maximising its value, announces that it has granted a total of 1,000,000 options over ordinary shares of 10p each in the Company ("Ordinary Shares", "Options") to certain Directors and senior executives of the Company.
The Company's admission document published in July 2022 stated that the Company may award share options to directors, employees and consultants (other than David Horner) and that any awards would be subject to vesting and/or performance conditions, and that the proportion of Ordinary Shares which would be subject to share options would not exceed 20 per cent.
The Options granted do not vest for two years (except in certain exceptional circumstances) and exercise is also subject to a number of performance conditions. The exercise price of the Options is 21.5p, being the mid-market price at the close of business on 26 April 2024, being the business day before the date of grant. The Options represent 10 per cent. of the Company's issued share capital.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | 1. Lindsay Mair 2. Richard Bucknell 3. Clive Milner 4. Rebecca Leigh
| ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | 1. Non-executive Chairman 2. Chief Investment Officer 3. Operations Manager 4. Investment Director
| ||||
| b)
| Initial notification /Amendment | Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Macaulay Capital plc | ||||
| b) | LEI | 213800ZJXFVLJQC7OV11 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10 pence each
ISIN: GB00BNKBMF25 | ||||
| b) | Nature of the transaction | Grant of Options
| ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | Volume: 1,000,000 Price: £0 | ||||
| e) | Date of the transaction | 29 April 2024 | ||||
| f) | Place of the transaction | UK | ||||
This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.
ENDS
Enquiries:
| Macaulay Capital PLC |
|
| Clive Milner | 44 (0)20 3946 5980 |
| | |
| Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
|
| Louise O'Driscoll | +44 (0)20 7213 0880 |
| |
|
| Oberon Capital (Broker) |
|
| Chris Crawford | +44 (0)20 3179 5304 |
For more information please visit: www.macaulaycapital.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
